We initially proposed the use of viral protein‐X (Vpx) as a biologic inhibitor of SAMHD1 to enhance ara‐C efficacy in AML which we demonstrated in cell models and primary patient material [14]. The gene discussed is SAMHD1; the disease is acute myeloid leukemia.